Fate Therapeutics, Inc. (FATE) has a market capitalization of $155.79M and trades at $1.34. The 52-week range is 0.68-1.94.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.2, Earnings Per Share (EPS) of $-1.15, annual revenue of $6.65M.
The stock has a beta of 2.24, operates in the Healthcare sector.
